Loading...
XNYSNVRO
Market cap123mUSD
Jan 10, Last price  
3.29USD
1D
-5.73%
1Q
-31.88%
Jan 2017
-95.47%
IPO
-87.00%
Name

Nevro Corp

Chart & Performance

D1W1MN
XNYS:NVRO chart
P/E
—
P/S
0.29
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
3.67%
Rev. gr., 5y
1.88%
Revenues
425m
+4.63%
18,150,00023,500,00032,573,00069,606,000228,504,000326,674,000387,289,000390,255,000362,048,000386,905,000406,365,000425,174,000
Net income
-92m
L
-18,967,000-26,014,000-30,680,000-67,431,000-31,778,000-36,658,000-49,205,000-103,686,000-83,065,000-131,360,0003,001,000-92,213,000
CFO
-59m
L
-22,467,000-21,095,000-31,148,000-100,430,000-58,503,000-14,273,000-5,708,000-50,225,0001,191,000-41,881,00024,675,000-58,829,000
Earnings
Feb 19, 2025

Profile

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
URL
https://www.nevro.com/
IPO date
Nov 06, 2014
Employees
1,087
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
425,174
4.63%
406,365
5.03%
Cost of revenue
189,532
183,063
Unusual Expense (Income)
NOPBT
235,642
223,302
NOPBT Margin
55.42%
54.95%
Operating Taxes
(5,646)
1,263
Tax Rate
0.57%
NOPAT
241,288
222,039
Net income
(92,213)
-3,172.74%
3,001
-102.28%
Dividends
Dividend yield
Proceeds from repurchase of equity
6,540
(2,457)
BB yield
-0.84%
0.17%
Debt
Debt current
5,722
5,195
Long-term debt
220,739
207,459
Deferred revenue
Other long-term liabilities
43,088
2,157
Net debt
(96,262)
(162,337)
Cash flow
Cash from operating activities
(58,829)
24,675
CAPEX
(8,594)
(7,542)
Cash from investing activities
(7,204)
64,290
Cash from financing activities
49,534
(2,457)
FCF
225,985
201,606
Balance
Cash
322,723
374,385
Long term investments
606
Excess cash
301,464
354,673
Stockholders' equity
(699,617)
(610,256)
Invested Capital
1,257,677
1,136,737
ROIC
20.15%
19.67%
ROCE
42.23%
42.41%
EV
Common stock shares outstanding
35,981
35,525
Price
21.52
-45.66%
39.60
-51.15%
Market cap
774,320
-44.96%
1,406,800
-50.17%
EV
678,058
1,244,463
EBITDA
247,177
233,629
EV/EBITDA
2.74
5.33
Interest
8,014
6,432
Interest/NOPBT
3.40%
2.88%